449 related articles for article (PubMed ID: 24943033)
1. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
Liu Y; Wang YF; Wang KL; Lv FF
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
[TBL] [Abstract][Full Text] [Related]
3. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
[TBL] [Abstract][Full Text] [Related]
4. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
ter Borg EJ; Kelder JC
Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
[TBL] [Abstract][Full Text] [Related]
6. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.
Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K
J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785
[TBL] [Abstract][Full Text] [Related]
7. [Significance of v-raf murine sarcoma viral oncogene homologue B1 in rheumatoid arthritis].
Jin YJ; Sun L; Yang L; Xing R; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):947-950. PubMed ID: 27987495
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
Haga HJ; Andersen DT; Peen E
Clin Rheumatol; 2011 Mar; 30(3):369-72. PubMed ID: 21234630
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis.
Ryu HJ; Takeuchi F; Kuwata S; Kim YJ; Lee EY; Lee EB; Song YW
Rheumatol Int; 2011 Mar; 31(3):315-9. PubMed ID: 20012964
[TBL] [Abstract][Full Text] [Related]
10. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
11. [Significance of IgA isotype of anti-v-raf murine sarcoma viral oncogene homologue B1 antibody in rheumatoid arthritis].
Jin YJ; Sun L; Zhao JX; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):631-635. PubMed ID: 37534643
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of primary Sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody.
Ryu YS; Park SH; Lee J; Kwok SK; Ju JH; Kim HY; Jeon CH
Rheumatol Int; 2013 Jun; 33(6):1443-6. PubMed ID: 23179261
[TBL] [Abstract][Full Text] [Related]
13. Anti-CCP antibodies and rheumatoid factor in systemic sclerosis: Prevalence and relationships with joint manifestations.
Wielosz E; Majdan M; Dryglewska M; Zwolak R
Adv Clin Exp Med; 2018 Sep; 27(9):1253-1257. PubMed ID: 30024658
[TBL] [Abstract][Full Text] [Related]
14. Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M; Yamada Y; Toumatu J
Clin Exp Rheumatol; 1998; 16(6):709-15. PubMed ID: 9844764
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA.
Agrawal S; Misra R; Aggarwal A
Clin Rheumatol; 2007 Feb; 26(2):201-4. PubMed ID: 16572283
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O; Gilburd B; Zandman-Goddard G; Sherer Y; Orbach H; Gerli R; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):197-202. PubMed ID: 16295525
[TBL] [Abstract][Full Text] [Related]
17. Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.
Atzeni F; Sarzi-Puttini P; Lama N; Bonacci E; Bobbio-Pallavicini F; Montecucco C; Caporali R
Arthritis Res Ther; 2008; 10(3):R51. PubMed ID: 18462485
[TBL] [Abstract][Full Text] [Related]
18. [Significance and diagnostic value of synovial fluid anti-cyclic citrullinated peptide antibody and anti-mutated citrullinated vimentin antibodies in patients with serum negative rheumatoid arthritis].
Qu SJ; Ye H; Jia RL; Li ZG
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):933-936. PubMed ID: 27987492
[TBL] [Abstract][Full Text] [Related]
19. Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome.
Barcelos F; Abreu I; Patto JV; Trindade H; Teixeira A
Acta Reumatol Port; 2009; 34(4):608-12. PubMed ID: 20087267
[TBL] [Abstract][Full Text] [Related]
20. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
